CAMP4 Therapeutics Corpor...

NASDAQ: CAMP · Real-Time Price · USD
1.67
0.12 (7.74%)
At close: Aug 15, 2025, 3:59 PM
1.67
0.30%
After-hours: Aug 15, 2025, 04:10 PM EDT

CAMP4 Therapeutics Income Statement

Financials in USD. Fiscal year is March - February.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Nov 30, 2023 Aug 31, 2023 May 31, 2023 Feb 28, 2023 Nov 30, 2022 Aug 31, 2022 May 31, 2022 Feb 28, 2022 Nov 30, 2021 Aug 31, 2021 May 31, 2021 Feb 28, 2021 Nov 30, 2020 Aug 31, 2020 May 31, 2020
Revenue
858K 652K n/a n/a n/a 53.63M 61.71M 70.89M 78.51M 78.89M 72.83M 64.73M 68.38M 68.78M 79.01M 79.67M 81.95M 88.01M 83.54M 80.22M
Cost of Revenue
n/a n/a n/a 9.56M 9.56M 36.05M 39.37M 43.83M 50.77M 52.27M 43.82M 39.08M 40.33M 40.76M 45.64M 47.23M 47.35M 53.01M 52.73M 49.16M
Gross Profit
858K 234K n/a n/a n/a 17.57M 22.34M 27.06M 27.74M 26.61M 29.01M 25.65M 28.05M 28.02M 33.37M 32.45M 34.6M 35.01M 30.81M 31.05M
Operating Income
-13.1M -14.03M -13.52M -12.66M -12.88M -83.42M -3.22M -2.51M -1.58M -3.63M -5.34M -9.34M -4.42M -6.56M -998K -1.23M -289K -20.01M -6.25M -9.91M
Interest Income
588K 610K 94K 231K 395K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-12.43M -13.28M -13.48M -12.58M -12.45M -84.97M -3.79M -3.98M -7.58M -4.46M -7.37M -11.92M -8.93M -10.34M -5.09M -5.71M -3.48M -23.36M -9.21M -14.18M
Net Income
-12.43M -13.28M -13.48M -12.58M -12.45M -85M -4.22M -4.03M -8.09M -4.73M -7.49M -12.17M -9.18M -11.44M -5.42M -1.95M -8.73M -23.68M -9.48M -14.42M
Selling & General & Admin
3.81M 4.69M 3.81M 3.27M 3.13M 19M 19.63M 22.38M 22.65M 23.66M 26.26M 26.64M 24.49M 26.01M 25.25M 25.15M 25.63M 28.29M 27.39M 26.55M
Research & Development
10.15M 10M 9.7M 9.56M 9.74M 4.05M 4.8M 5.84M 5.33M 5.48M 6.76M 7M 6.6M 7.18M 7.73M 6.94M 6.89M 6.78M 6.99M 6.32M
Other Expenses
n/a n/a n/a -9.56M -9.56M -17K 723K 1.22M 1.34M 1.32M 1.33M 1.34M 1.38M -98K -710K -1.28M -360K -52K 217K -208K
Operating Expenses
13.96M 14.69M 13.52M 12.66M 3.2M 24.16M 25.56M 29.44M 29.32M 30.46M 34.35M 34.98M 32.47M 34.58M 34.37M 33.34M 33.73M 36.93M 36.23M 34.77M
Interest Expense
n/a n/a n/a n/a n/a 1.41M 1.57M 1.68M 1.61M 1.65M 1.46M 1.53M 3.84M 3.83M 3.8M 3.85M 3.67M 3.88M 3.86M 4.08M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a 8.88M 9.62M 11.02M 10.69M 12.49M 12.73M 11.48M 10.82M 13.24M 12.05M 12.46M 12.46M 14.65M 13.49M 12.89M
Cost & Expenses
13.96M 14.69M 13.52M 12.66M 12.88M 60.22M 64.93M 73.27M 80.08M 82.73M 78.17M 74.06M 72.8M 75.34M 80.01M 80.57M 81.08M 89.93M 88.95M 83.93M
Income Tax Expense
n/a n/a n/a n/a n/a 38K 435K 52K 508K 268K 126K 249K 256K 205K 333K 293K -264K 319K 266K 240K
Shares Outstanding (Basic)
19.51M 19.51M 19.51M 15.81M 12.12M 37.43M 36.99M 36.63M 36.13M 36.36M 35.69M 35.72M 35.55M 35.14M 35.15M 34.84M 34.68M 33.98M 34.26M 34.02M
Shares Outstanding (Diluted)
19.51M 19.51M 19.51M 15.81M 12.12M 37.43M 36.99M 36.63M 36.13M 36.36M 36.01M 35.72M 35.55M 35.48M 35.15M 34.84M 34.69M 34.6M 34.26M 34.02M
EPS (Basic)
-0.64 -0.68 -0.69 -0.8 -1.03 -2.27 -0.11 -0.11 -0.22 -0.13 -0.21 -0.34 -0.26 -0.33 -0.15 -0.06 -0.25 -0.7 -0.28 -0.42
EPS (Diluted)
-0.64 -0.68 -0.69 -0.8 -1.03 -2.27 -0.11 -0.11 -0.22 -0.13 -0.21 -0.34 -0.26 -0.32 -0.15 -0.06 -0.25 -0.68 -0.28 -0.42
EBITDA
-12.68M -13.62M -13.1M -12.24M -12.44M -1.66M 3.1M 3.04M -387K 1.58M -4.52M -4.78M -3.4M -690K 3.93M 3.31M 1.72M 4.91M 1.72M 2.88M
EBIT
-13.1M -14.03M -13.52M -12.66M -12.88M n/a n/a -2.51M -1.58M -3.63M -5.34M -9.34M -4.42M n/a n/a n/a n/a n/a n/a n/a
Depreciation & Amortization
421K 418K 418K 424K 436K 4.95M 5.59M 5.55M 1.19M 5.22M 823K 4.56M 1.02M 5.97M 5.64M 5.48M 1.21M 6.88M 6.92M 6.8M